(MM) (GEVA) Notizie

Data	Ora	Fonte	Titolo	Simbolo	Compagnia
06/07/2015	18:14	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:GEVA	(MM)
29/06/2015	23:31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:GEVA	(MM)
24/06/2015	15:44	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:GEVA	(MM)
24/06/2015	12:06	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GEVA	(MM)
23/06/2015	23:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GEVA	(MM)
23/06/2015	14:55	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GEVA	(MM)
23/06/2015	14:21	Edgar (US Regulatory)	(25-NSE)	NASDAQ:GEVA	(MM)
23/06/2015	14:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GEVA	(MM)
23/06/2015	12:30	Business Wire	Alexion Completes Acquisition of Synageva	NASDAQ:GEVA	(MM)
22/06/2015	14:54	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:GEVA	(MM)
22/06/2015	14:32	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:GEVA	(MM)
22/06/2015	14:31	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:GEVA	(MM)
10/06/2015	17:32	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GEVA	(MM)
04/06/2015	22:05	PR Newswire (US)	Synageva BioPharma Completes Targeted Enrollment in Phase 1/2 Trial with SBC-103 for Mucopolysaccharidosis IIIB	NASDAQ:GEVA	(MM)
03/06/2015	01:29	Business Wire	SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Synageva BioPharma Corp.	NASDAQ:GEVA	(MM)
26/05/2015	22:05	PR Newswire (US)	Synageva BioPharma Submits Kanuma™ (Sebelipase Alfa) Application For LAL Deficiency In Japan	NASDAQ:GEVA	(MM)
22/05/2015	22:41	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:GEVA	(MM)
22/05/2015	22:31	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:GEVA	(MM)
22/05/2015	17:26	PR Newswire (US)	SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Synageva BioPharma Corp. -GEVA	NASDAQ:GEVA	(MM)
18/05/2015	22:10	PR Newswire (US)	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synageva BioPharma Corp. of Commencement of an Investigation...	NASDAQ:GEVA	(MM)
18/05/2015	20:28	Business Wire	SYNAGEVA BIOPHARMA CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Synageva BioPharma Corp. Over th...	NASDAQ:GEVA	(MM)
18/05/2015	18:18	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 4th Update	NASDAQ:GEVA	(MM)
18/05/2015	17:05	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 3rd Update	NASDAQ:GEVA	(MM)
18/05/2015	15:20	Dow Jones News	Endo to Buy Par Pharma	NASDAQ:GEVA	(MM)
18/05/2015	14:53	Dow Jones News	Endo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd Update	NASDAQ:GEVA	(MM)
18/05/2015	13:44	Dow Jones News	Endo to Buy Generics Maker Par Pharma for About $8 Billion -- Update	NASDAQ:GEVA	(MM)
13/05/2015	22:37	Business Wire	SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Synageva BioPharma Corp. And Encourages ...	NASDAQ:GEVA	(MM)
11/05/2015	23:22	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:GEVA	(MM)
10/05/2015	19:03	The Motley Fool	Investors Just Doubled Their Money on This Stock	NASDAQ:GEVA	(MM)
10/05/2015	17:06	The Motley Fool	Will Suitors Line Up to Buy These Biotech Stocks Next?	NASDAQ:GEVA	(MM)

GEVA

(MM) (GEVA)

News di Agenzia

La tua Cronologia

Più Attivi

Toplist

GEVA

(MM) (GEVA)

News di Agenzia

La tua Cronologia